Comparador de Empresas

Acerca de

Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.

Ingresos

$52.8B

Señal de brecha de noticias

Señales institucionales

Patrones en cascada

Relaciones clave

Acerca de

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Ingresos

$130.5B

Señal de brecha de noticias

Señales institucionales

Patrones en cascada

Relaciones clave